Trastuzumab is a monoclonal antibody used to treat HER2-positive breast cancer by binding to the HER2 receptor and inhibiting tumor growth. It is administered intravenously and can be used in combination therapy. The term denotes a biotechnology-derived therapeutic protein, not a small-molecule drug.
Full pronunciation guide
